Federal Register of Legislation - Australian Government

Primary content

PB 4 of 2011 Other as made
This instrument amends the National Health (Trastuzumab) Special Arrangement 2010 (No. PB 115 of 2010) to provide for the addition of a new form of trastuzumab (Powder for I.V. infusion 60mg) to be covered by this Special Arrangement.
Administered by: Health
Registered 31 Jan 2011
Tabling HistoryDate
Tabled HR08-Feb-2011
Tabled Senate09-Feb-2011
Date of repeal 01 Dec 2011
Repealed by National Health (Trastuzumab) Special Arrangement 2011 (No. PB 94 of 2011)

 

PB 4 of 2011

National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No. 1)

 

National Health Act 1953

___________________________________________________________________________

 

I, FELICITY MCNEILL, Acting First Assistant Secretary, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under subsections 100(1) and (2) of the National Health Act 1953.

Dated    26     January 2011

 

 

 

 

 

 

 

 

 

 

 

FELICITY MCNEILL

Acting First Assistant Secretary

Pharmaceutical Benefits Division

Department of Health and Ageing

___________________________________________________________________

 

 

 

 

 

1              Name of Instrument

 

(1)                This Instrument is the National Health (Trastuzumab) Special Arrangement Amendment Instrument 2011 (No.1).

 

(2)                This Instrument may also be cited as PB 4 of 2011.

 

2                Commencement

                            This Instrument commences on 1 February 2011.

3              Amendments to PB 115 of 2010

                            Schedule 1 amends PB 115 of 2010.

 

 


Schedule 1                   Amendments

 

[1]          Section 4, definition of authorised prescriber, before trastuzumab

omit:

the

 

insert:

a

 

[2]          Section 4, Note after definition of authorised prescriber

substitute:

 

Note  Section 5 sets out the pharmaceutical benefits to which this Special Arrangement applies and section 8 sets out the prescriber code for those pharmaceutical benefits.

 

[3]          Section 4, definition of trastuzumab pharmaceutical benefit, after means

omit:

the

 

insert:

a

 

[4]          Subsection 5(1), after applies to

omit:

the

 

insert:

each

 

[5]          Subsection 5(2), before trastuzumab

omit:

The

 

insert:

Each

 

[6]          Subsection 6(1), before trastuzumab

omit:

The

 

insert:

Each

 

[7]          Note 1 after section 7, before trastuzumab

omit:

The

 

insert:

Each

 

[8]          Subsection 8(1), after for the

insert:

supply of a

 

[9]          Subsection 9(1), after supply of a

insert:

trastuzumab

 

[10]        Subsection 9(2), after For subsection (1),

omit:

the

 

insert:

a

 

[11]        Subsection 10(2), before trastuzumab

omit:

The

 

insert:

A

 

[12]        Subsection 11(1), after applies to

omit:

the

 

insert:

a

 

[13]        Section 14, after quantity of

omit:

the

 

insert:

a

 

[14]        Section 15, after repeats of

omit:

the

 

insert:

a

 

[15]        Section 16, after prescription for

omit:

the

 

insert:

a

 

[16]        Section 17, after to receive

omit:

the

 

insert:

a

 

 

[17]        Section 18, before trastuzumab

omit:

The

 

insert:

A

 

[18]        Section 19, after supplies

omit:

the

 

insert:

a

 

[19]        Subsection 20(2), after supply of

omit:

the

 

insert:

a

 

[20]        Paragraph 20(2)(a), after reference to

omit:

the

 

insert:

a

 

[21]        Paragraph 21(a), after supplies

omit:

the

 

insert:

a

 

[22]        Paragraph 22(c), after supply of

omit:

the

 

insert:

a

 

[23]        Subsection 23(1), after supply of

omit:

the

 

insert:

a

 

[24]        Subsection 23(2), after price of

omit:

the

 

insert:

a

 

[25]        Subsection 23(2), after reference to

omit:

the

 

insert:

a

 

[26]        Paragraph 24(a), after supplies

omit:

the

 

insert:

a

 

[27]        Paragraph 25(2)(c), after prescription for

omit:

the

 

insert:

a

 

[28]        Note after section 25, after certain

omit:

circumstances”

 

insert:

circumstances.

 

[29]        Section 26, after reference to

omit:

the

 

insert:

a

 

[30]        Subsection 28(1), after practitioner supplies

omit:

the

 

insert:

a

 

[31]        Subsection 29(1), after hospital supplies

omit:

the

 

insert:

a

 

[32]        Subparagraph 30(1)(a)(i), after supplies

omit:

the

 

insert:

a

 

[33]        Subparagraph 30(1)(b)(i), after supplies

omit:

the

 

insert:

a

 

[34]        Section 31, after supplies of

omit:

the

 

insert:

a

 

[35]       Schedule 1, entry for Trastuzumab

insert as first entry in the columns in the order indicated

Trastuzumab

Powder for I.V. infusion 60mg

Injection

Herceptin

RO

MP

D

 

Note

All legislative instruments and compilations are registered on the Federal Register of Legislative Instruments kept under the Legislative Instruments Act 2003.

See http://www.frli.gov.au